|
Research & Development
|
42.24M | 65.23M | 73.30M |
|
Selling, General & Administrative
|
18.06M | 19.76M | 22.81M |
|
Other Operating Expenses
|
-0.32M | 0.21M | |
|
Operating Expenses
|
60.30M | 84.99M | 96.12M |
|
Operating Income
|
-60.30M | -84.99M | -96.12M |
|
EBIT
|
-60.30M | -84.99M | -96.12M |
|
Other Non Operating Income
|
-0.01M | -0.08M | -0.12M |
|
Non Operating Income
|
1.53M | 8.72M | 9.31M |
|
EBT
|
-58.76M | -76.27M | -86.81M |
|
Tax Provisions
|
| 0.14M | 0.11M |
|
Profit After Tax
|
-58.76M | -76.41M | -86.92M |
|
Income from Continuing Operations
|
-58.76M | -76.41M | -86.92M |
|
Consolidated Net Income
|
-58.76M | -76.41M | -86.92M |
|
Income towards Parent Company
|
-58.76M | -76.41M | -86.92M |
|
Net Income towards Common Stockholders
|
-58.76M | -76.41M | -86.92M |
|
EPS (Basic)
|
-1.96 | -1.93 | -1.75 |
|
EPS (Weighted Average and Diluted)
|
-1.96 | -1.93 | -1.75 |
|
Shares Outstanding (Weighted Average)
|
29.33M | 38.26M | 50.23M |
|
EBITDA
|
-60.30M | -75.80M | -87.19M |